Literature DB >> 954010

Nitrosourea chemotherapy for primary malignant gliomas.

V A Levin, C B Wilson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 954010

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN: 0361-5960


× No keyword cloud information.
  15 in total

Review 1.  Paediatric and adult malignant glioma: close relatives or distant cousins?

Authors:  Chris Jones; Lara Perryman; Darren Hargrave
Journal:  Nat Rev Clin Oncol       Date:  2012-05-29       Impact factor: 66.675

Review 2.  Nitrosoureas in the Management of Malignant Gliomas.

Authors:  Alba A Brandes; Marco Bartolotti; Alicia Tosoni; Enrico Franceschi
Journal:  Curr Neurol Neurosci Rep       Date:  2016-02       Impact factor: 5.081

3.  Targeting brain tumors by intra-arterial delivery of cell-penetrating peptides: a novel approach for primary and metastatic brain malignancy.

Authors:  Shailendra Joshi; Johann R N Cooke; Jason A Ellis; Charles W Emala; Jeffrey N Bruce
Journal:  J Neurooncol       Date:  2017-09-05       Impact factor: 4.130

4.  Radiotherapy and combination chemotherapy with carmustine, vincristine, and procarbazine (BVP) in primary brain tumors.

Authors:  G Comella; G Scoppa; M De Marco; G P Ianniello; G Melillo; F Coucourde; D Zarrilli
Journal:  J Neurooncol       Date:  1985       Impact factor: 4.130

5.  Improved delivery through biological membranes. XLV. Synthesis, physical-chemical evaluation, and brain uptake studies of 2-chloroethyl nitrosourea delivery systems.

Authors:  K Raghavan; T Loftsson; M E Brewster; N Bodor
Journal:  Pharm Res       Date:  1992-06       Impact factor: 4.200

Review 6.  State of the art and perspectives in the treatment of glioblastoma.

Authors:  Sean A Grimm; Marc C Chamberlain
Journal:  CNS Oncol       Date:  2012-09

7.  Interrelationship between O6-alkylguanine-DNA alkyltransferase activity and susceptibility to chloroethylnitrosoureas in several glioma cell lines.

Authors:  T Hotta; Y Saito; T Mikami; K Kurisu; K Kiya; T Uozumi; G Isowa; K Ishizaki; M Ikenaga
Journal:  J Neurooncol       Date:  1993-07       Impact factor: 4.130

8.  BCNU stability as a function of ethanol concentration and temperature.

Authors:  P Tepe; S J Hassenbusch; R Benoit; J H Anderson
Journal:  J Neurooncol       Date:  1991-04       Impact factor: 4.130

9.  Phase III randomized trial comparing the efficacy of cediranib as monotherapy, and in combination with lomustine, versus lomustine alone in patients with recurrent glioblastoma.

Authors:  Tracy T Batchelor; Paul Mulholland; Bart Neyns; L Burt Nabors; Mario Campone; Antje Wick; Warren Mason; Tom Mikkelsen; Surasak Phuphanich; Lynn S Ashby; John Degroot; Rao Gattamaneni; Lawrence Cher; Mark Rosenthal; Franz Payer; Juliane M Jürgensmeier; Rakesh K Jain; A Gregory Sorensen; John Xu; Qi Liu; Martin van den Bent
Journal:  J Clin Oncol       Date:  2013-08-12       Impact factor: 44.544

10.  O6-alkylguanine-DNA alkyltransferase activity of human malignant glioma and its clinical implications.

Authors:  T Hotta; Y Saito; H Fujita; T Mikami; K Kurisu; K Kiya; T Uozumi; G Isowa; K Ishizaki; M Ikenaga
Journal:  J Neurooncol       Date:  1994       Impact factor: 4.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.